Chonluten
Research profile · How we handle evidence
Khavinson bioregulator peptide researched for lung epithelium and respiratory tissue support.
Evidence Score
Preclinical signal
Category
Therapeutic area
Standard Dose
Daily
Half-life
Plasma elimination
Route
Subcutaneous or Intranasal
Safety Tier
Limited data
Overview
Chonluten (Glu-Asp-Gly) is a short bioregulator peptide associated with respiratory tissue support. The common framing is tissue-level “maintenance,” not an immediate symptom switch.
Mechanism of Action
Chonluten (Glu-Asp-Gly) is a short bioregulator peptide associated with respiratory tissue support. The common framing is tissue-level “maintenance,” not an immediate symptom switch.
pH & Mixing
Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.
A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.
Benefits
- Respiratory support
- Lung function improvement
- Anti-inflammatory
- Tissue protection
Side Effects
- Generally well-tolerated
Contraindications
- Pregnant or breastfeeding women
Structure & Sequence
Verified structure
Chonluten
Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.
- Amino Acid Sequence
- Glu-Asp-Gly (EDG)
- Molecular Weight
- 319.27 Da
- Chemical Formula
- C11H17N3O8
- CAS Number
- N/A
- Reconstituted pH
- 3.7
Stack & Route Context
Stacks with
- Thymosin Alpha-1
- VIP
Administration
Subcutaneous or Intranasal
Research Status
Research peptide for respiratory health
Approval Status
Preclinical
Sports Legal
Permitted
References
- 1View source
Peptides regulating proliferative activity and inflammatory pathways in THP-1 cells includes Chonluten
2022
- 2View source
Chonluten — Khavinson peptide products catalog entry
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.